Gisele Nishiguchi
- Genetics top 5%
- Molecular Biology
- Organic Chemistry top 10%
- Oncology
- Endocrinology, Diabetes and Metabolism top 10%
- Co-authors
- John A. KatzenellenbogenShaun R. StaufferJun SunBenita S. KatzenellenbogenRosanna TedescoKathryn E. CarlsonR. Daniel LittleZoran Ranković
- Topics
- Protein Degradation and Inhibitors (7 papers)Synthesis and biological activity (4 papers)Ubiquitin and proteasome pathways (4 papers)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Gisele Nishiguchi
18 papers receiving 920 citations
Hit Papers
Peers
Comparison fields: 5 of 82
- Genetics 441
- Molecular Biology 304
- Organic Chemistry 299
- Oncology 148
- Endocrinology, Diabetes and Metabolism 143
Countries citing papers authored by Gisele Nishiguchi
This map shows the geographic impact of Gisele Nishiguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gisele Nishiguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gisele Nishiguchi more than expected).
Fields of papers citing papers by Gisele Nishiguchi
This network shows the impact of papers produced by Gisele Nishiguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gisele Nishiguchi. The network helps show where Gisele Nishiguchi may publish in the future.
Co-authorship network of co-authors of Gisele Nishiguchi
This figure shows the co-authorship network connecting the top 25 collaborators of Gisele Nishiguchi. A scholar is included among the top collaborators of Gisele Nishiguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gisele Nishiguchi. Gisele Nishiguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 3 | |
| 4 | 19 | |
| 5 | 1 | |
| 6 | 44 | |
| 7 | 24 | |
| 8 | 22 | |
| 9 | 8 | |
| 10 | 2 | |
| 11 | 4 | |
| 12 | 13 | |
| 13 | 47 | |
| 14 | 8 | |
| 15 | 24 | |
| 16 | 15 | |
| 17 | 22 | |
| 18 | 7 | |
| 19 | Pyrazole Ligands: Structure−Affinity/Activity Relationships and Estrogen Receptor-α-Selective Agonistsbreakdown → | 675 |
About Gisele Nishiguchi
Gisele Nishiguchi is a scholar working on Toxicology, Hematology and Organic Chemistry, having authored 19 papers that have together received 941 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (7 papers), Synthesis and biological activity (4 papers) and Ubiquitin and proteasome pathways (4 papers). The work is most often cited by research in Behavioral Neuroscience (59 citations), Genetics (441 citations) and Toxicology (47 citations). Gisele Nishiguchi has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include John A. Katzenellenbogen, Shaun R. Stauffer, Jun Sun, Benita S. Katzenellenbogen, Rosanna Tedesco, Kathryn E. Carlson, R. Daniel Little, Zoran Ranković, Alice L. Rodriguez and Mika Lindvall. Their work appears in journals such as Blood, Cancer Research and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.